Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Buse DC, Manack AN, Serrano D, et al. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Headache. 2012;52:3–17.
2. Chowdhury S, Dave T. Novel oral CGRP receptor antagonist atogepant in the prevention of migraine. Discov Craiova Rom. 2023;11: e167.
3. Russo AF, Hay DL. CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev. 2023;103:1565–644.
4. Karsan N, Gosalia H, Goadsby PJ. Molecular mechanisms of migraine: nitric oxide synthase and neuropeptides. Int J Mol Sci. 2023;24:11993.
5. Page MJ, McKenzie JE, Bossuyt PM, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021: n71.